Hospital for Special Surgery, Weill Cornell Medicine
Oral abstract session. Contains 5 abstracts.
Presentations:
3:00 PM – 3:10 PM ET
Cytotoxic T Cells with a Chronic Antigen Exposure Phenotype Drive Immune Checkpoint Inhibitor Sicca Blake M. Warner, PhD, MPH, DDS – National Institutes of Health
3:10 PM – 3:20 PM ET
In Vitro Characterization of Inflammatory Arthritis Associated with Immune Check Point Inhibition Anne Sofie Sørensen, -None- – Aarhus University
3:20 PM – 3:30 PM ET
Prevalence, Therapy and Tumor Response in Patients with Rheumatic Immune-related Adverse Events Following Immune Checkpoint Inhibitor Therapy: A Single-Centre Analysis Valentin S. Schäfer, MD, PhD – University Hospital Bonn
3:30 PM – 3:40 PM ET
Recombinant Zoster Vaccine in Patients with Rheumatic Diseases: A Retrospective Study of 622 Patients Tiphaine Lenfant, MD – Cleveland Clinic Foundation
3:40 PM – 3:50 PM ET
Monitoring of BK Reactivation and Long-term Safety on JAK1/2 Inhibition with Baricitinib Kader Cetin Gedik, MD – Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH
.jpg "Anne Bass, MD photo")
